Abstract
ObjectiveMelanoma has been shown in numerous studies to be associated with sun exposure, and with host phenotypic factors of genetic origin. In this study we use information from a large series of incident cases of melanoma from an international population-based study to examine the patterns of incidence of melanoma in the first-degree relatives of these cases. Methods: A total of 2508 incident cases of melanoma provided information on basic demographic data and pigmentary characteristics, in addition to detailed information on family history of melanoma. These data were used to examine the incidence rates ratios of melanoma in the relatives of cases in relation to population rates, and also with respect to phenotypic characteristics of the probands that have been shown to be associated with melanoma: mole counts, hair color, eye color, and skin sensitivity to the sun. Results: The incidence rates reflect the underlying patterns of incidence in the source populations, with generally higher rates in the Australian sample, low rates in Italy, and intermediate rates in the USA and Canada. Also, rates are higher in men than in women, except at very young ages. Phenotypic characteristics of the probands were only weakly associated with the observed rates in the relatives although there is a strong inverse association with age at diagnosis. Cumulative risk of melanoma rises to 6.9 (6.1) at age 80 in male (female) first-degree relatives of cases, and to 10.8 (9.5) in relatives of cases diagnosed before age 50. Conclusions: Relatives of cases diagnosed with melanoma are at considerable lifetime risk of the disease, especially if the case is diagnosed at a young age.
Similar content being viewed by others
References
Armstrong BK, Kricker A (1994) Cutaneous melanoma. In: Cancer Surveys Voume 19:Trends in Cancer Incidence and Mortality. Imperial Cancer Research Fund, London.
Boyle P, Maisonneuve P, Dore JF (1995) Epidemiology of malignant melanoma. Br Med Bull 51:523–547.
Elwood JM (1993) Recent developments in melanoma epidemiol-ogy, 1993. Melanoma Res 3:149–156.
Bliss JM, Ford D, Swerdlow AJ, et al. (1995) Risk of cutaneous melanoma associated with pigmentation characteristics and freck-ling:systematic overview of 10 case –control studies. Int J Cancer 62:367–376.
Kamb A, Gruis NA, Weaver-Feldhous J, et al. (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436–440.
Holland EA, Beaton SC, Becker TM, et al. (1995) Analysis of the p16 gene, CDKN2, in 17 Australian kindreds. Oncogene 11:2289–2294.
Goldstein AM, Tucker MA (2001) Genetic epidemiology of cutaneous melanoma:a global perspective. Arch Dermatol 137: 1493–1496.
Saunders CL, Begg CB (2003) Kin-cohort evaluation of relative risks of genetic variants. Genet Epidemiol 24:220–229.
Begg CB (2002) On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst 94:1221–1226.
Fitzpatrick TB (1975) Soleil et peau. J Med Esthet 2:33.
Ries LAG, Eisner MP, Kosary CL, et al. eds. (2002) SEER Cancer Statistics Review 1973 –1999, Bethesda, MD:National Cancer Institute. Also available from: URL:http://seer. cancer. gov/csr/ 1973–1999.
Stata® (2001) Reference Manual, Release 7, College Station, Texas: Stata Press.
Aitken JF, Duffy DL, Green A, Youl P, MacLennan R, Martin NG (1994) Heterogeneity of melanoma risk in families of melanoma patients. Am J Epidemiol 140:961–973.
Ford D, Bliss JM, Swerdlow AJ, et al. (1995) Risk of cutaneous melanoma associated with a family history of the disease. Int J Cancer 62:377–381.
Risch N (1990) Linkage strategies for genetically complex traits:I. multilocus models. Am J Hum Genet 46:222–228.
Hemminki K, Zhang H, Czene K (2003) Familial and attributable risks in cutaneous melanoma:effects of proband and age. J Invest Dermatol 120:217–223.
Begg CB (2001) The search for cancer risk factors:when can we stop looking? Am J Public Health 91:360–364.
Swerdlow AJ, Green A (1987) Melanocytic naevi and melanoma: an epidemiologic perspective. Br J Dermatol 117:137–146.
Swerdlow AJ, English J, Mackie RM, et al. (1986) Benign melanocytic naevi as a risk factor for melanoma. Br Med J 292: 1555–1559.
Holly EA, Kelly SW, Shpall SN, Chiu SH (1987) Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 17:459–468.
Roush GC, Norlund JJ, Forget B, Gruber SB, Kirkwood JM (1988) Independence of dysplastic nevi from total nevi in deter-mining risk for non-familial melanoma. Prev Med 17:273–279.
Grob JJ, Gouvernet J, Aymar D, et al. (1990) Count of benign melanocytic nevi as a major indicator of risk for non-familial nodular and super cial spreading melanoma. Cancer 66:387–395.
Augustsson A, Stierner U, Rosdahl I, Suurkula M(1990) Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in Swedish population. Acta Derm Verereol 71: 518–524.
Kruger S, Garke C, Buttner P, Stadler R, Guggenmoos-Holzmann I, Orfaros C (1992) Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutane-ous malignant melanoma. J Am Acad Dermatol 26:920–926.
Bataille V, Newton Bishop JA, Sasieni P, et al. (1996) Risk of cutaneous melanoma in relation to the numbers, types and sitzes of naevi:a case-control study. Br J Cancer 73:1605–1611.
Tucker MA, Halpern A, Holly EA, et al. (1997) Clinically recognized dysplastic nevi:a central risk factor for cutaneous melanoma. JAMA 277:1439–1444.
Brogelli L, DeGiorgi V, Bini F, Giannotti B (1991) Melanocytic naevi:clinical features and correlation with the phenotype in healthy young males in Italy. Br J Dermatol 125:349–352.
Dennis L, White E, Lee JAH, Kristal A, McKnight B, Odland P (1996) Constitutional factors and sun exposure in relation to nevi: a population-based cross-sectional study. Am J Epidemiol 143: 248–256.
Dennis LK, White E, McKnight B, Kristal A, Lee JAH, Odland P (1996) Nevi and migration within the United States and Canada:a population-based cross-sectional study. Cancer Causes Control 7: 464–473.
Carli P, Naldi L, Lovati S, LaVecchia C (1996) The density of melanocytic nevi correlates with constitutional variables and history of sunburns:a prevalence study among Italian schoolchil-dren. Int J Cancer 101:375–379.
Dulon M, Weichenthal M, Blettner M, et al. (2002) Sun exposure and number of nevi in 5-to 6-year old European children. J Clin Epidemiol 55:1075–1081.
Wiecker TS, Luther H, Buettner P, Bauer J, Garbe C (2003) Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood. Cancer 97: 628–638.
Wachsmuth RC, Gaut RM, Barrett JH, et al. (2001) Heritability and gene –environment interactions for melanocytic nevus density examined in a UK adolescent twin study. J Invest Dermatol 117: 348–352.
Zhu G, Duffy DL, Eldridge A, et al. (1999) A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A:a maximum-likelihood combined linkage and association analysis in twins and their sibs. Am J Hum Genet 65: 483–492.
Foon PW, Scheuner MT, Paterson-Oshlke KL, Gwinn M, Faucett A, Khoury MJ (2002) Can family history be used as a tool for public health and preventive medicine? Genet Med 4: 304–320.
Feightner JW (1994) Prevention of skin cancer. In:Canadian Task Force on Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa: Health Canada, pp. 850–859.
http://www. health. gov. au/nhmrc/publications/pdf/cp68. pdf
US Preventive Services Task Force (2001) Screening for skin cancer:recommendations and rationale. Am J Prev Med 20:44–46.
Clegg LX, Feuer EJ, Midthune DN, Fay MP, Hankey BJ (2002) Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst 94:1537–1545.
Ziogas A, Anton-Culver H (2003) Validation of family history data in cancer family registries. Am J Prev Med 24:190–198.
Aitken JF, Youl P, Green A, MacLennan R, Martin NG (1996) Accuracy of case-reported family history of melanoma in Queens-land, Australia. Melanoma Res 6:313–317.
Marrett LD, Nguyen HL, Armstrong BK (2001) Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983 –1996. Int J Cancer 92:457–462.
Gaudette LA, Gao RN (1998) Changing trends in melanoma incidence and mortality. Health Rep 10:29–41.
Buettner PG, Garbe C (2000) Agreement between self-assessment of melanocytic nevi by patients and dermatologic examination. Am J Epidemiol 151:72–77.
Harrison SL, Buettner PG, MacLemmon R, Kelly JW, Rivers JK (2002) How good are parents at assessing melanocytic nevi on their children? study comparing parental counts, dermatologist counts, and counts obtained from photographs. Am J Epidemiol 155:1128–1136.
Bain C, Colditz GA, Willett WC, et al. (1998) Self-reports of mole counts and cutaneous malignant melanoma in women: methodological issues and risk of disease. Am J Epidemiol 127: 703–712.
English DR, Armstrong BK (1994) Melanocytic nevi in children. II. Observer variation in counting nevi. Am J Epidemiol 139: 402–407.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Begg, C.B., Hummer, A., Mujumdar, U. et al. Familial aggregation of melanoma risks in a large population-based sample of melanoma cases. Cancer Causes Control 15, 957–965 (2004). https://doi.org/10.1007/s10522-004-2474-2
Issue Date:
DOI: https://doi.org/10.1007/s10522-004-2474-2